Clearmind Medicine Inc. (NASDAQ ... According to data from Benzinga Pro, the stock experienced above-average trading volume of 3.60 million shares compared to its average volume of 71,163.

The study builds on a growing body of research suggesting 3D mammography could offer benefits over 2D imaging.

Here are three biotech stocks to consider today. "Golden Age of Medicine" Stock #1: Eli Lilly and Company (LLY) Headquartered in Indianapolis, Indiana, Eli Lilly is a 148-year-old company—yet it ...

GE HealthCare Technologies’ GEHC MIM Software recently announced the receipt of FDA clearance for performing Centiloid ...

Replacing 10 percent of ultra-processed foods with healthier alternatives lowered diabetes risk by up to 18 percent, a new study says.

Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration The global psychedelic drugs market is projected to grow by USD 1.37 billion by 2028 ...

The FDA’s decision to reject MDMA-assisted therapy was a big blow to the psychedelics sector, but Mind Medicine remains confident ... I/we have no stock, option or similar derivative position ...

Aug. 30, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ ... does not mean that the stock will go down. For example, biotech and... Presented positive data for all three programs at the ...

FDA complaint states that accused illegally distributed non-existent stock of anaesthesia medicine tonics in bottles to ...

Follow Jiangsu Hengrui Medicine stock price in real-time on Markets Insider here. Jiangsu Hengrui Medicine will report earnings from 2 on August 22. 2 analysts are expecting earnings of CNY 0.390 ...

Disc Medicine (IRON – Research Report), the Healthcare ... Analyst Douglas Tsao from H.C. Wainwright reiterated a Buy rating on the stock and has a $70.00 price target. Douglas Tsao has given ...